Former lenders to Parallel, the struggling hashish multistate operator as soon as led by chewing-gum inheritor William “Beau” Wrigley, finalized their takeover of firm property this week, based on a Monday announcement.
And after buying “sure” Parallel property in Florida, Massachusetts and Texas, Canadian hashish and liquor big SNDL now claims a retail footprint of 249 licensed places – “the biggest on the planet by retailer depend,” CEO Zach George claimed in a press launch Monday.
As a part of the acquisition, SNDL, which has been buying properties throughout Canada for the previous few years, now operates:
- Surterra Wellness and 43 medical marijuana dispensaries and a 175,000-square-foot cultivation facility in Florida
- Goodbled and its 10 retail and pickup places in Texas, which final 12 months tremendously expanded its medical hashish program
- Massachusetts-based NETA and its three retail places and single cultivation and manufacturing facility
What occurred to hashish firm Parallel and Surterra Wellness?
It’s the most recent improvement in a long-running saga for Parallel and its subsidiaries, which defaulted on a $150 million mortgage amid general debt obligations in extra of $842 million, SNDL mentioned in its launch Monday.
And it’s the most recent instance of a hashish firm taken over by its former lenders. Earlier this 12 months, an affiliate of Boston-based Millstreet Capital Administration, which loaned money to Ayr Wellness, took over that firm’s vertically built-in medical hashish allow in Virginia.
In Parallel’s case, SNDL took over the corporate after “an intensive advertising and marketing course of … didn’t end in a suitable third-party transaction,” based on Monday’s press launch.
The finalization of SNDL’s takeover of Parallel, first introduced in April, additionally follows the closure of two Surterra Wellness cultivation services in Florida, based on a July 21 missive from Parallel Florida to state officers.
Someday this previous month, Parallel shuttered cultivation operations in Wimauma and Lakeland, the place it had previously employed 211 individuals, the corporate mentioned in a federally mandated Employee Adjustment and Retraining (WARN) Act discover.
Wrigley took over as CEO of Surterra Wellness in 2018. The corporate rebranded to Parallel and rapidly launched into an bold enlargement plan. Nonetheless, Wrigley stepped down as CEO in 2021 after a plan to take the corporate public at a $1.9 billion valuation through a particular acquisition firm (SPAC) fell aside.
Wrigley was later sued by his former traders. And landlords throughout the nation started submitting fits for unpaid hire.
What’s the biggest hashish firm on the planet?
For now, SNDL has oblique majority management of the previous Parallel property by way of its affiliate SunStream Bancorp, which additionally took over troubled Michigan operator Skymint.
It plans to maintain the adult-use hashish operations in Michigan “deconsolidated” to adjust to Nasdaq necessities, based on Monday’s announcement.
That also makes SNDL “one of many first” corporations listed on Nasdaq to have U.S.-based hashish operations.
Subscribe to the MJBiz Factbook
Unique trade information and evaluation that can assist you make knowledgeable enterprise selections and keep away from pricey missteps. All of the information, not one of the hype.
What you’re going to get:
- Month-to-month and quarterly updates, with new information & insights
- Monetary forecasts + capital funding developments
- State-by-state information to rules, taxes & market alternatives
- Annual survey of hashish companies
- Client insights
- And extra!
Mainstream exchanges have only recently proven curiosity in U.S.-based hashish operators.
Final month, the New York Inventory Change listed Florida-based MSO Trulieve Hashish Corp. and California-based cultivator Glass Home Manufacturers, after the businesses restructured to turn into medical-only and pursued registration with the U.S. Drug Enforcement Administration following the Trump administration’s reclassification of medical marijuana as a Schedule 3 drug.
In his assertion, George, the SNDL CEO, mentioned that the “classes realized from Canada’s intensely aggressive hashish market – together with navigating regulatory complexity and extreme tax charges – will serve us nicely as we broaden in key U.S. medical hashish markets akin to Florida, Massachusetts, and Texas.”

